Mitoxantrone in secondary progressive multiple sclerosis: a review of toxicity in 41 patients

Author： Peak Scott   Tsao-Wei Denice D   Chamberlain Marc C  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.4, Iss.1, 2007-01, pp. : 55-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta‐interferon exposure and onset of secondary progressive multiple sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 990-1000

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten‐year prognosis in multiple sclerosis: a better outcome in relapsing−remitting patients but not in primary progressive patients

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 507-e35

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Comparison of Self-Hypnosis Versus Progressive Muscle Relaxation in Patients With Multiple Sclerosis and Chronic Pain

By Jensen Mark   Barber Joseph   Romano Joan   Molton Ivan   Raichle Katherine   Osborne Travis   Engel Joyce   Stoelb Brenda   Kraft George   Patterson David  

International Journal of Clinical and Experimental Hypnosis, Vol. 57, Iss. 2, 2009-04 ,pp. : 198-221

Routledge Ltd

Access to resources Recommend Favorite

A benefit–risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy

By Walker Anna   Watson Crystal   Alexopoulos Stamatia T.   Deniz Baris   Arnold Ryan   Bates David  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 629-635

Informa Healthcare

Access to resources Recommend Favorite

Effects of current treatments in progressive retinal nerve fiber layer loss in multiple sclerosis patients

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite